Catalyst’s stemmed arthroplasty system earns FDA clearance

Medical device company Catalyst received FDA clearance for its total shoulder arthroplasty system. 

Advertisement

The system is the first to include an ellipsoid humeral head, which allows for more accurate restoration of natural joint kinematics, according to a Feb. 9 news release. 

Catalyst will have a limited release of the product in the second quarter of 2023 and a larger commercial release later in the year, the release said. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.